calendar
5,381 catalysts · 5,063 phase readout · 2,323 8k filing · 316 pdufa · 273 earnings · 108 phase 2 completion · 50 phase 1 completion
5,381 catalysts · 5,063 phase readout · 2,323 8k filing · 316 pdufa · 273 earnings · 108 phase 2 completion · 50 phase 1 completion
no tagged catalysts yet
Sponsor: University Medical Center Groningen. Phase: . Conditions: Differentiated Thyroid Cancer, Thyroid Cancer, Levothyroxine, Liothyronine, Thyroid Hormones
Sponsor: The George Institute. Phase: PHASE3. Conditions: Chronic Kidney Diseases, Dialysis-dependent Kidney Failure, Cardiovascular Disease
Sponsor: EMD Serono Research & Development Institute, Inc.. Phase: PHASE1. Conditions: Metastatic or Locally Advanced Unresectable Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.. Phase: PHASE2. Conditions: Stargardt's Macular Dystrophy
Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences. Phase: PHASE1. Conditions: Tetanus, Diphtheria and Acellular Pertussis Vaccination, Tetanus, Diphtheria, Pertussis, Pertussis Vaccines
Sponsor: Universidad Nacional de la Matanza. Phase: NA. Conditions: Neck Pain
Sponsor: Alexion Pharmaceuticals, Inc.. Phase: PHASE3. Conditions: Hypophosphatasia
Sponsor: Sakarya University. Phase: NA. Conditions: Pregnancy
Sponsor: Universitas Syiah Kuala. Phase: PHASE1. Conditions: Dry Skin, Xerosis Cutis
Sponsor: Metropolitan College. Phase: NA. Conditions: Overweight, Overweight and Obesity, Adiposity
Sponsor: Amager Hospital. Phase: NA. Conditions: Pregnancy Loss, Early, Major Depression, Anxiety, Stress (Psychology)
Sponsor: Sanofi. Phase: PHASE3. Conditions: Gaucher's Disease Type I, Gaucher's Disease Type III
Sponsor: University of Oxford. Phase: . Conditions: Hemorrhage, Trauma, Gastro Intestinal Bleeding
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Leukemia, Lymphoma, Graft-versus-host Disease
Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Small Lymphocytic Lymphoma, Refractory Transformed Chronic Lymphocytic Leukemia
Sponsor: Yale University. Phase: NA. Conditions: Heart Failure, Palliative Care
Sponsor: Islamia University of Bahawalpur. Phase: NA. Conditions: Psoriasis
Sponsor: Sheba Medical Center. Phase: PHASE2. Conditions: Williams Syndrome
Sponsor: Shanghai Zhongshan Hospital. Phase: PHASE1. Conditions: Biliary Tract Cancer, Candonilimab, Claudin 18.2
Sponsor: Alexandria University. Phase: NA. Conditions: Percutaneous Nephrolithotomy (PCNL)
Sponsor: University of British Columbia. Phase: NA. Conditions: Menstrual Cycle
Sponsor: Eupraxia Pharmaceuticals Inc.. Phase: PHASE1. Conditions: Eosinophilic Esophagitis
Sponsor: Seung-Jung Park. Phase: . Conditions: Coronary Stenosis, Coronary Occlusion, Coronary Disease
Sponsor: Fudan University. Phase: PHASE3. Conditions: Thyroid Cancer
Sponsor: University of California, San Francisco. Phase: NA. Conditions: Chronic Pain
Sponsor: Oklahoma State University Center for Health Sciences. Phase: NA. Conditions: Stress
Sponsor: Near East University, Turkey. Phase: NA. Conditions: Nausea and Vomiting Chemotherapy-Induced, Meditation Training
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Breast Abscess
Sponsor: Canadian Cancer Trials Group. Phase: PHASE2. Conditions: Lung Cancer
Sponsor: University of California, Los Angeles. Phase: . Conditions: Anorexia in Adolescence
Sponsor: Assiut University. Phase: . Conditions: Family Planning
Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: Type2 Diabetes, Life Style
Sponsor: Intermountain Health Care, Inc.. Phase: NA. Conditions: Cardiovascular Primary Prevention Strategy
Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Glioblastoma, Radiotherapy, Chemotherapy
Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Solid Tumors
Sponsor: Georgetown University. Phase: PHASE2. Conditions: Chronic Lymphocytic Leukemia
Sponsor: University of California, San Francisco. Phase: PHASE2. Conditions: Overdose Accidental
Sponsor: University Hospital, Grenoble. Phase: PHASE1. Conditions: Osteoarthritis
Sponsor: Oregon Health and Science University. Phase: NA. Conditions: Child Sleep
Sponsor: University of Florida. Phase: PHASE2. Conditions: Prostate
Sponsor: Shalvata Mental Health Center. Phase: . Conditions: Anxiety, Depression - Major Depressive Disorder, Bipolar, Schizophenia Disorder
Sponsor: François Delvoye. Phase: . Conditions: Ischemic Stroke, Cerebral Veinous Thrombosis
Sponsor: Özge İşeri. Phase: NA. Conditions: Anxiety, Recovery Quality
Sponsor: Boehringer Ingelheim. Phase: . Conditions: Pulmonary Fibrosis
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital. Phase: NA. Conditions: Coronary Artery Disease Progression
Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Major Depressive Disorder
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China. Phase: PHASE4. Conditions: NSCLC (Advanced Non-small Cell Lung Cancer), VTE (Venous Thromboembolism), Rash Due to Epidermal Growth Factor Receptor Inhibitors, Infusion Reaction
Sponsor: Region Skane. Phase: . Conditions: Ventilator Acquired Pneumonia, Mechanical Ventilation Complication
Sponsor: Antonio Fojo. Phase: PHASE2. Conditions: Neuroendocrine Tumors
Sponsor: Edwards Lifesciences. Phase: NA. Conditions: Cardiopulmonary Bypass Surgery